Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals

Journal of Hospital Infection

Volumn 66, Issue 3, 2007, Pages 243-248

  Gravel, D ^a   Taylor, G ^b   Ofner, M ^a   Johnston, L ^c   Loeb, M ^d   Roth, V R ^e   Stegenga, J ^a   Bryce, E ^d   the Canadian Nosocomial Infection Surveillance Program, ^f   Matlow, Anne ^f,g  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cross transmission; Healthcare acquired infections; Infection control; Prevalence

Indexed keywords

AMINOGLYCOSIDE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CANADA; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; EMERGENCY CARE; FEMALE; HEALTH CARE; HOSPITAL INFECTION; HUMAN; INDUSTRIALIZATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CANADA; CROSS INFECTION; FEMALE; HEALTH SURVEYS; HOSPITALS; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PREVALENCE;

EID: 34250797372     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.04.008     Document Type: Article

References (25)

1. Haley R.W., Culver D.H., White J.W., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121 (1985) 182-205
2. French G.L., Cheng A.F.B., Wong S.L., and Donnan S. Repeated prevalence surveys for monitoring effectiveness of hospital infection control. Lancet 28 (1989) 1021-1023
3. Weinstein J.W., Mazon D., Pantelick E., Reagan-Cirincione P., Dembry L.M., and Hierholzer W.J. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol 20 (1999) 543-548
4. Gikas A., Pediaditis I., Roumbelaki M., et al. Repeated multi-centre prevalence surveys of hospital-acquired infection in Greek hospital. J Hosp Infect 41 (1999) 11-18
5. Sax G., Hugonnet S., Harbarth S., Herrault P., and Pittet D. Variation in nosocomial infection prevalence according to patient care settings: a hospital wide survey. J Hosp Infect 48 (2001) 27-32
6. Freeman J., Rosner B.A., and McGowan J.E. Adverse effects of nosocomial infection. J Infect Dis 140 (1979) 732-740
7. French G.L., and Cheng A.F.B. Measurement of the costs of hospital infection by prevalence surveys. J Hosp Infect 18 Suppl. A (1991) 65-72
8. Harbarth S., Ruef C., Francoli P., Widmer A., and Pittet D. Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience. Schweiz Med Wochenschr 129 (1999) 1521-1528
9. Sramova H., Bartonova A., Bolek S., Krecmerova M., and Subertova V. Frequency of nosocomial infections as revealed by a prevalence survey. J Hyg Epidemiol Microbiol Immunol 32 (1988) 39-47
10. Maderova E., Kertnerova V., Cervenka J., and Pucekova C. Prevalence of nosocomial infections in selected hospitals. J Hyg Epidemiol Microbiol Immunol 31 (1987) 365-374
11. Kampf G., Gastmeier P., Wischnewski N., et al. Analysis of risk factors for nosocomial infections - results from the first national prevalence survey in Germany (NIDEP study, part 1). J Hosp Infect 37 (1997) 103-112
12. Emmerson A.M., Enstone J.E., Griffith M., Kelsey M.C., and Smyth E.T.M. The second national prevalence survey of infection in hospitals - overview of the results. J Hosp Infect 32 (1996) 175-190
13. Scheel O., and Stormark M. National prevalence survey on hospital infections in Norway. J Hosp Infect 41 (1998) 331-335
14. Vaqué J., Rossello J., Arribas J.L., and EPINE Working Group. Prevalence of nosocomial infections in Spain: EPINE study 1990-1997. J Hosp Infect 43 Suppl: (1999) S105-S111
15. Gastmeier P., Sohr D., Rath A., et al. Repeated prevalence investigations on nosocomial infections for continuous surveillance. J Hosp Infect 45 (2000) 47-53
16. Pittet D., Harbarth S., Ruef C., et al. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 20 (1999) 37-42
17. Floret N., Bailly P., Bertrand X., et al. Results from a four-year study on the prevalence of nosocomial infections in Franche-Comté: attempt to rank the risk of nosocomial infection. J Hosp Infect 63 (2006) 393-398
18. French Prevalence Survey Study Group. Prevalence of nosocomial infections in France: results of the nationwide survey in 1996. J Hosp Infect 46 (2000) 186-193
19. Astagneau P., Fleury L., Leroy S., et al. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 42 (1999) 303-312
20. Gravel D., Matlow A., Ofner M., et al. A point prevalence survey of healthcare associated infections in pediatric populations in major Canadian acute-care hospitals. Am J Infect Control 35 (2007) 157-162
21. CDC. CDC definitions of nosocomial infections; 2004.
22. Health Canada. Infections control guidelines for preventing infections associated with indwelling intravascular access devices. CCDR 1997; 2358.
23. Health Canada. Infection control guidelines: routine practices and additional precautions for preventing the transmission of infection in health care. CCDR 1999. Report No. 25S4.
24. Johnson S.J., and Gerding D.N. Clostridium difficile. In: Mayhall C.G. (Ed). Hospital epidemiology and infection control. 2nd ed. (1999), Lippincott, Williams & Wilkins, Philadelphia, PA 467-476
25. Gastmeier P., Brauer H., Sohr D., et al. Converting incidence and prevalence data of nosocomial infections: results from eight hospitals. Infect Control Hosp Epidemiol 22 (2001) 31-34